Anfield Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,795
| Closed | -$1.91M | – | 128 |
|
|
2021
Q4 | $1.91M | Buy |
26,795
+315
| +1% | +$22.4K | 0.66% | 33 |
|
|
2021
Q3 | $1.98M | Buy |
26,480
+630
| +2% | +$47.2K | 0.62% | 35 |
|
|
2021
Q2 | $2M | Buy |
25,850
+630
| +2% | +$48.7K | 0.76% | 25 |
|
|
2021
Q1 | $1.86M | Sell |
25,220
-2,121
| -8% | -$157K | 0.74% | 29 |
|
|
2020
Q4 | $1.92M | Sell |
27,341
-3,232
| -11% | -$227K | 0.82% | 33 |
|
|
2020
Q3 | $1.73M | Sell |
30,573
-7,272
| -19% | -$412K | 1% | 28 |
|
|
2020
Q2 | $2.21M | Buy |
37,845
+17,814
| +89% | +$1.04M | 0.87% | 24 |
|
|
2020
Q1 | $931K | Sell |
20,031
-136
| -0.7% | -$6.32K | 0.54% | 32 |
|
|
2019
Q4 | $1.01M | Buy |
+20,167
| New | +$1.01M | 0.41% | 42 |
|